Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Health Affairs (Project Hope)|July 14, 2005
Opening Pandora's pillbox: using modern information tools to improve drug safetyScott GottliebHealth Affairs (Project Hope)|May 9, 2007
Drug safety proposals and the intrusion of federal regulation into patient freedom and medical practiceScott GottliebAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 18, 2008
Biosimilars: policy, clinical, and regulatory considerationsScott GottliebAmerican Journal of Clinical Dermatology|February 26, 2004
The wrinkle severity rating scale: a validation studyDoris J Day, Curt M Littler, Richard W Swift, et al.Health Affairs (Project Hope)|January 21, 2021
Health Costs And Financing: Challenges And Strategies For A New AdministrationWilliam H Shrank, Nancy-Ann DeParle, Scott Gottlieb, et al.Dermatology and Therapy|January 7, 2026
Real-World Benefit of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: Findings from a Systematic Literature Review and Meta-AnalysisScott Gottlieb, Aaron S Farberg, Neal Bhatia, et al.Pharmacogenomics|December 15, 2010
Learning from product labels and label changes: how to build pharmacogenomics into drug-development programsLinda C Surh, Michael A Pacanowski, Susanne B Haga, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2010
NCCN Oncology Risk Evaluation and Mitigation Strategies White Paper: Recommendations for StakeholdersPhilip E Johnson, George Dahlman, Kirby Eng, et al.The Pan African Medical Journal|November 7, 2019
[HIV-2 infection in Senegal: virological failures and resistance to antiretroviral drugs (ARVs)]Selly Ba, Ndeye Mery Dia-Badiane, Stephen Edward Hawes, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2011
NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectivesAndrew D Zelenetz, Islah Ahmed, Edward Louis Braud, et al.Pageof 2